GEODE CAPITAL MANAGEMENT, LLC - CYCLO THERAPEUTICS INC ownership

CYCLO THERAPEUTICS INC's ticker is CYTH and the CUSIP is 23254X201. A total of 16 filers reported holding CYCLO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CYCLO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$142,780
-10.5%
100,507
+0.1%
0.00%
Q2 2023$159,616
+263.2%
100,388
+92.1%
0.00%
Q1 2023$43,944
+59283.8%
52,2530.0%0.00%
Q4 2022$74
-99.9%
52,253
+8.1%
0.00%
Q3 2022$93,000
-3.1%
48,3160.0%0.00%
Q2 2022$96,000
-37.3%
48,3160.0%0.00%
Q1 2022$153,000
-12.1%
48,316
+3.1%
0.00%
Q4 2021$174,000
-49.9%
46,848
-9.0%
0.00%
Q3 2021$347,000
-20.2%
51,454
+20.8%
0.00%
Q2 2021$435,000
+191.9%
42,577
+133.2%
0.00%
Q1 2021$149,00018,2570.00%
Other shareholders
CYCLO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 930,000$1,320,6000.02%
ROYAL BANK OF CANADA 746$1,0000.00%
VANGUARD GROUP INC 253,882$360,5120.00%
UBS Group AG 2,810$3,9900.00%
IFP Advisors, Inc 13$10.00%
OSAIC HOLDINGS, INC. 600$1,0000.00%
BANK OF AMERICA CORP /DE/ 18$260.00%
WELLS FARGO & COMPANY/MN 2,301$3,2680.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 52,253$740.00%
View complete list of CYCLO THERAPEUTICS INC shareholders